<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Protagonist Therapeutics, Inc (PTGX) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/ptgx/filings</link>
    <description>Latest company filings for Protagonist Therapeutics, Inc (PTGX) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Fri, 10 Jul 2026 02:36:43 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/ptgx/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[PTGX: Insider trade (amended) (4/A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926061476/xslF345X06/tm2614674-1_4aseq1.xml</link>
      <guid isPermaLink="false">0001104659-26-061476</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider trade (amended) (4/A) on 2026-05-14.]]></description>
      <pubDate>Thu, 14 May 2026 12:00:00 GMT</pubDate>
      <category>4/A</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000196858226000430/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001968582-26-000430</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider sale notice (144) on 2026-05-12.]]></description>
      <pubDate>Tue, 12 May 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926059591/xslF345X06/tm2614444-1_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-059591</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider trade (4) on 2026-05-12.]]></description>
      <pubDate>Tue, 12 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926058860/xslF345X06/tm2614277-1_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-058860</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider trade (4) on 2026-05-11.]]></description>
      <pubDate>Mon, 11 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000195004726004264/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-004264</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider sale notice (144) on 2026-05-08.]]></description>
      <pubDate>Fri, 08 May 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000195004726004220/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-004220</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider sale notice (144) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000195004726004218/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-004218</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider sale notice (144) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926055661/ptgx-20260331x10q.htm</link>
      <guid isPermaLink="false">0001104659-26-055661</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Quarterly report (10-Q) on 2026-05-05.]]></description>
      <pubDate>Tue, 05 May 2026 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926055629/tm2613550d1_8k.htm</link>
      <guid isPermaLink="false">0001104659-26-055629</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Major company event (8-K) on 2026-05-05.]]></description>
      <pubDate>Tue, 05 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[PTGX: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000210011926000884/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0002100119-26-000884</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-04-30.]]></description>
      <pubDate>Thu, 30 Apr 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[PTGX: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000210012126000589/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0002100121-26-000589</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Annual report to shareholders (ARS)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926050443/tm262955d2_ars.pdf</link>
      <guid isPermaLink="false">0001104659-26-050443</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Annual report to shareholders (ARS) on 2026-04-28.]]></description>
      <pubDate>Tue, 28 Apr 2026 12:00:00 GMT</pubDate>
      <category>ARS</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Proxy materials (DEFA14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926050440/tm261434d3_defa14a.htm</link>
      <guid isPermaLink="false">0001104659-26-050440</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Proxy materials (DEFA14A) on 2026-04-28.]]></description>
      <pubDate>Tue, 28 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEFA14A</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Proxy statement (DEF 14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926050429/tm261434-1_def14a.htm</link>
      <guid isPermaLink="false">0001104659-26-050429</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Proxy statement (DEF 14A) on 2026-04-28.]]></description>
      <pubDate>Tue, 28 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEF 14A</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926048572/xslF345X06/tm2612651-1_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-048572</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider trade (4) on 2026-04-24.]]></description>
      <pubDate>Fri, 24 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926046110/xslF345X06/tm2612380-2_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-046110</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider trade (4) on 2026-04-21.]]></description>
      <pubDate>Tue, 21 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926046107/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001104659-26-046107</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider sale notice (144) on 2026-04-21.]]></description>
      <pubDate>Tue, 21 Apr 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926036319/xslF345X06/tm2610129-3_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-036319</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider trade (4) on 2026-03-27.]]></description>
      <pubDate>Fri, 27 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926036318/xslF345X06/tm2610129-2_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-036318</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider trade (4) on 2026-03-27.]]></description>
      <pubDate>Fri, 27 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926036317/xslF345X06/tm2610129-1_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-036317</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider trade (4) on 2026-03-27.]]></description>
      <pubDate>Fri, 27 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[PTGX: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000010290926002110/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000102909-26-002110</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-03-27.]]></description>
      <pubDate>Fri, 27 Mar 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000195004726003020/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-003020</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider sale notice (144) on 2026-03-26.]]></description>
      <pubDate>Thu, 26 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000195004726003018/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-003018</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider sale notice (144) on 2026-03-26.]]></description>
      <pubDate>Thu, 26 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000195004726003011/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-003011</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider sale notice (144) on 2026-03-26.]]></description>
      <pubDate>Thu, 26 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926034736/xslF345X06/tm269861-1_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-034736</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider trade (4) on 2026-03-25.]]></description>
      <pubDate>Wed, 25 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000196858226000318/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001968582-26-000318</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider sale notice (144) on 2026-03-24.]]></description>
      <pubDate>Tue, 24 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Employee stock plan (S-8)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926019736/tm266947d1_s8.htm</link>
      <guid isPermaLink="false">0001104659-26-019736</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Employee stock plan (S-8) on 2026-02-25.]]></description>
      <pubDate>Wed, 25 Feb 2026 12:00:00 GMT</pubDate>
      <category>S-8</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Annual report (10-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926019696/ptgx-20251231x10k.htm</link>
      <guid isPermaLink="false">0001104659-26-019696</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Annual report (10-K) on 2026-02-25.]]></description>
      <pubDate>Wed, 25 Feb 2026 12:00:00 GMT</pubDate>
      <category>10-K</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926019658/tm267184d1_8k.htm</link>
      <guid isPermaLink="false">0001104659-26-019658</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Major company event (8-K) on 2026-02-25.]]></description>
      <pubDate>Wed, 25 Feb 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926017176/xslF345X05/tm266755-1_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-017176</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider trade (4) on 2026-02-18.]]></description>
      <pubDate>Wed, 18 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000195004726001404/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-001404</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider sale notice (144) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[PTGX: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000149321526000042/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001493215-26-000042</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[PTGX: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000090221926000033/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000902219-26-000033</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-02-10.]]></description>
      <pubDate>Tue, 10 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000195004726000988/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-000988</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider sale notice (144) on 2026-02-06.]]></description>
      <pubDate>Fri, 06 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926011575/xslF345X05/tm265544-1_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-011575</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider trade (4) on 2026-02-06.]]></description>
      <pubDate>Fri, 06 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[PTGX: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000090883426000054/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000908834-26-000054</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-02-06.]]></description>
      <pubDate>Fri, 06 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[PTGX: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000010290926000253/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000102909-26-000253</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-01-30.]]></description>
      <pubDate>Fri, 30 Jan 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000195004726000710/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-000710</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider sale notice (144) on 2026-01-27.]]></description>
      <pubDate>Tue, 27 Jan 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000195004726000698/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-000698</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider sale notice (144) on 2026-01-27.]]></description>
      <pubDate>Tue, 27 Jan 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926007129/xslF345X05/tm264253-3_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-007129</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider trade (4) on 2026-01-27.]]></description>
      <pubDate>Tue, 27 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926007128/xslF345X05/tm264253-2_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-007128</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider trade (4) on 2026-01-27.]]></description>
      <pubDate>Tue, 27 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926007127/xslF345X05/tm264253-1_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-007127</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider trade (4) on 2026-01-27.]]></description>
      <pubDate>Tue, 27 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000195004726000681/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-000681</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider sale notice (144) on 2026-01-26.]]></description>
      <pubDate>Mon, 26 Jan 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000196858226000059/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001968582-26-000059</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider sale notice (144) on 2026-01-23.]]></description>
      <pubDate>Fri, 23 Jan 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000195004726000655/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-000655</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider sale notice (144) on 2026-01-23.]]></description>
      <pubDate>Fri, 23 Jan 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926005443/xslF345X05/tm263774-3_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-005443</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider trade (4) on 2026-01-21.]]></description>
      <pubDate>Wed, 21 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926005442/xslF345X05/tm263774-2_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-005442</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider trade (4) on 2026-01-21.]]></description>
      <pubDate>Wed, 21 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926005440/xslF345X05/tm263774-1_4seq1.xml</link>
      <guid isPermaLink="false">0001104659-26-005440</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider trade (4) on 2026-01-21.]]></description>
      <pubDate>Wed, 21 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926005438/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001104659-26-005438</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider sale notice (144) on 2026-01-21.]]></description>
      <pubDate>Wed, 21 Jan 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[PTGX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1377121/000110465926005437/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001104659-26-005437</guid>
      <description><![CDATA[Protagonist Therapeutics, Inc filed a Insider sale notice (144) on 2026-01-21.]]></description>
      <pubDate>Wed, 21 Jan 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
  </channel>
</rss>